-
1
-
-
84856200634
-
Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: Mortality results after 13 years of follow-up
-
the PLCO Project Team
-
GL Andriole, ED Crawford, RL Grubb 3rd the PLCO Project Team Prostate cancer screening in the randomized prostate, lung, colorectal, and ovarian cancer screening trial: mortality results after 13 years of follow-up J Natl Cancer Inst 104 2012 125 132
-
(2012)
J Natl Cancer Inst
, vol.104
, pp. 125-132
-
-
Andriole, G.L.1
Crawford, E.D.2
Grubb Iii., R.L.3
-
2
-
-
63249118690
-
Screening and prostate-cancer mortality in a randomized European study
-
the ERSPC Investigators
-
FH Schroder, J Hugosson, MJ Roobol the ERSPC Investigators Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320 1328
-
(2009)
N Engl J Med
, vol.360
, pp. 1320-1328
-
-
Schroder, F.H.1
Hugosson, J.2
Roobol, M.J.3
-
3
-
-
84919871373
-
Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
-
for the ERSPC Investigators published online Aug 7
-
FH Schroder, J Hugosson, MJ Roobol for the ERSPC Investigators Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up Lancet 2014 published online Aug 7. http://dx.doi.org/10.1016/S0140-6736(14)60525-0
-
(2014)
Lancet
-
-
Schroder, F.H.1
Hugosson, J.2
Roobol, M.J.3
-
4
-
-
77950519549
-
Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity
-
IJ Powell, CH Bock, JJ Ruterbusch, W Sakr Evidence supports a faster growth rate and/or earlier transformation to clinically significant prostate cancer in black than in white American men, and influences racial progression and mortality disparity J Urol 183 2010 1792 1797
-
(2010)
J Urol
, vol.183
, pp. 1792-1797
-
-
Powell, I.J.1
Bock, C.H.2
Ruterbusch, J.J.3
Sakr, W.4
-
5
-
-
2442715038
-
Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4·0 ng per milliliter
-
IM Thompson, DK Pauler, PJ Goodman et al. Prevalence of prostate cancer among men with a prostate-specific antigen level < or = 4·0 ng per milliliter N Engl J Med 350 2004 2239 2246
-
(2004)
N Engl J Med
, vol.350
, pp. 2239-2246
-
-
Thompson, I.M.1
Pauler, D.K.2
Goodman, P.J.3
-
6
-
-
40949147326
-
Quality of life and satisfaction with outcome among prostate cancer survivors
-
MG Sanda, RL Dunn, J Michalski et al. Quality of life and satisfaction with outcome among prostate cancer survivors N Engl J Med 358 2008 1250 1261
-
(2008)
N Engl J Med
, vol.358
, pp. 1250-1261
-
-
Sanda, M.G.1
Dunn, R.L.2
Michalski, J.3
-
7
-
-
73949130115
-
Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer
-
L Klotz, L Zhang, A Lam, R Nam, A Mamedov, A Loblaw Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer J Clin Oncol 28 2010 126 131
-
(2010)
J Clin Oncol
, vol.28
, pp. 126-131
-
-
Klotz, L.1
Zhang, L.2
Lam, A.3
Nam, R.4
Mamedov, A.5
Loblaw, A.6
-
8
-
-
33751018522
-
Adjuvant radiotherapy for pathologically advanced prostate cancer: A randomized clinical trial
-
IM Thompson, CM Tangen, J Paradelo et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335
-
(2006)
JAMA
, vol.296
, pp. 2329-2335
-
-
Thompson, I.M.1
Tangen, C.M.2
Paradelo, J.3
-
9
-
-
39149085396
-
Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: Long-term results of RTOG 8610
-
M Roach 3rd, K Bae, J Speight et al. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610 J Clin Oncol 26 2008 585 591
-
(2008)
J Clin Oncol
, vol.26
, pp. 585-591
-
-
Roach Iii., M.1
Bae, K.2
Speight, J.3
-
10
-
-
38349164176
-
Androgen suppression and radiation vs radiation alone for prostate cancer: A randomized trial
-
AV D'Amico, MH Chen, AA Renshaw, M Loffredo, PW Kantoff Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial JAMA 299 2008 289 295
-
(2008)
JAMA
, vol.299
, pp. 289-295
-
-
D'Amico, A.V.1
Chen, M.H.2
Renshaw, A.A.3
Loffredo, M.4
Kantoff, P.W.5
-
11
-
-
84864008031
-
Radical prostatectomy versus observation for localized prostate cancer
-
for the Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group
-
TJ Wilt, MK Brawer, KM Jones for the Prostate Cancer Intervention versus Observation Trial (PIVOT) Study Group Radical prostatectomy versus observation for localized prostate cancer N Engl J Med 367 2012 203 213
-
(2012)
N Engl J Med
, vol.367
, pp. 203-213
-
-
Wilt, T.J.1
Brawer, M.K.2
Jones, K.M.3
-
12
-
-
33646459214
-
Assessing prostate cancer risk: Results from the Prostate Cancer Prevention Trial
-
IM Thompson, DP Ankerst, C Chi et al. Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 529-534
-
-
Thompson, I.M.1
Ankerst, D.P.2
Chi, C.3
|